Response Genetics, Inc. (NASDAQ:RGDX) reported to sign contracts with 6 additional healthcare plans across 10 states with which it raised its total contracted membership to around 174 million lives. Response Genetics, Inc. (NASDAQ:RGDX) shares after opening at $1.35 moved to $1.56 on last trade day and at the end of the day closed at $1.42. Company price to sales ratio in past twelve months was calculated as 2.68 and price to cash ratio as 11.94. Response Genetics, Inc. (NASDAQ:RGDX) showed a positive weekly performance of 26.79%.
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) announced the pricing of its previously announced underwritten public offering of 11,325,000 shares of its common stock at an offering price of $2.21 per share. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) shares advanced 8.60% in last trading session and ended the day on $2.40. CPRX return on equity ratio is recorded as -73.10% and its return on assets is -59.70%. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) yearly performance is 433.33%.
RadNet, Inc. (NASDAQ:RDNT) was a big mover last session, as its shares rose nearly 12% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. RadNet Inc. (NASDAQ:RDNT) shares moved up 5.28% in last trading session and was closed at $3.39, while trading in range of $3.19 – $3.46. RadNet Inc. (NASDAQ:RDNT) year to date (YTD) performance is 102.99%.
On April 2, 2014, Magellan Petroleum Corporation (NASDAQ:MPET) announced that the Company will be presenting at IPAA’s OGIS New York conference to be held at the Sheraton NY Times Square Hotel in New York City on April 7. Magellan Petroleum Corporation (NASDAQ:MPET) weekly performance is 13.57%. On last trading day company shares ended up $1.59. Magellan Petroleum Corporation (NASDAQ:MPET) distance from 50-day simple moving average (SMA50) is 23.62%. Analysts mean target price for the company is $2.40.